Purpose: To evaluate possible differences in the prevalence of clinica
lly detectable foveal lesions between patients with type I and type 2
Usher's syndrome. Methods: Records of 48 patients with type 1 and 98 p
atients with type 2 Usher's syndrome were retrospectively evaluated fo
r the presence of a foveal lesion. The age, gender, and racial distrib
ution of patients were similar in the two subtypes. Two investigators
reviewed fundus photographs from all patients and, when available, flu
orescein angiograms. Results: In the 48 patients with type I Usher's s
yndrome, 30 (62%) showed a clinically apparent atrophic-or cystic-appe
aring foveal lesion, whereas in the 98 patients with type 2 Usher's sy
ndrome, 33 (34%) had either an atrophic-or a cystic-appearing foveal l
esion. Logistic regression analysis showed that the probability of exh
ibiting a foveal lesion in both type 1 and type 2 Usher's syndrome inc
reases with age and that patients with type 1 Usher's syndrome are mor
e likely to have a foveal lesion than are patients with type 2 Usher's
syndrome. Conclusions: Patients with type 1 Usher's syndrome show a g
reater probability of having either an atrophic or cystic-appearing fo
veal lesion than do patients with type 2 Usher's syndrome. This higher
prevalence of foveal lesions is consistent with a previous observatio
n that the severity of visual acuity impairment with age is greater fo
r patients with type 1 than type 2 Usher's syndrome. These data are us
eful in counseling such patients as to their prognosis for central vis
ual function.